Adage Capital Partners Gp, L.L.C. Astrazeneca PLC Transaction History

Adage Capital Partners Gp, L.L.C.

$54.6 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $23.1 Million - $28 Million	346,468 New	346,468 $27 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $27.7 Million - $30.6 Million	426,822 Added 42.13%	1,439,929 $97.5 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $49.9 Million - $54.1 Million	713,107 Added 237.7%	1,013,107 $72.5 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $61.7 Million - $69.9 Million	-976,725 Reduced 76.5%	300,000 $20.8 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $43.5 Million - $56.5 Million	802,021 Added 168.95%	1,276,725 $86.6 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $2.51 Million - $6.42 Million	-47,256 Reduced 9.05%	474,704 $26 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $11.1 Million - $13.4 Million	-188,040 Reduced 26.48%	521,960 $34.5 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $2.23 Million - $2.68 Million	-40,000 Reduced 5.33%	710,000 $47.1 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $111 Million - $132 Million	-2,063,663 Reduced 73.34%	750,000 $43.7 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $156 Million - $171 Million	2,813,663 New	2,813,663 $169 Million
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $32.8 Million - $39.2 Million	-675,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $26.5 Million - $30.6 Million	500,000 Added 285.71%	675,000 $37 Million
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $16.2 Million - $20.7 Million	-375,000 Reduced 68.18%	175,000 $9.26 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $5.67 Million - $7.7 Million	150,000 Added 37.5%	550,000 $24.6 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $4.25 Million - $5.05 Million	-100,000 Reduced 20.0%	400,000 $19.9 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $20.1 Million - $22.7 Million	500,000 New	500,000 $22.3 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $17.7 Million - $21.5 Million	-500,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $29.5 Million - $33.8 Million	-850,000 Reduced 62.96%	500,000 $19.8 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $20.7 Million - $22.2 Million	-600,000 Reduced 30.77%	1,350,000 $47.4 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $4.95 Million - $5.49 Million	-150,000 Reduced 7.14%	1,950,000 $68.2 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $20.9 Million - $22.6 Million	650,000 Added 44.83%	2,100,000 $72.9 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $42 Million - $49.3 Million	1,450,000	1,450,000 $49.1 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account